IHS Chemical Week

World News and Views :: Top of the News

Codexis sells its operations in Hungary to US biotech firm Intrexon

11:12 AM MDT | March 14, 2014 | Deepti Ramesh

Codexis (Redwood City, CA), a developer of biocatalysts for the pharmaceutical and fine chemical industries, says it has sold its subsidiary and laboratory operations at Budapest, to biotechnology company Intrexon (Germantown, MD), for a purchase price of $1.5 million. The transaction closed on 13 March. No proprietary Codexis materials or intellectual property were included in the transaction, Codexis says. “We were able to transfer our dedicated and talented employees in Hungary to Intrexon and to monetize one of our assets as part of the wind down of our...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa